Biochip Market Qualitative analysis by Industry Trends, Opportunities, Technology and Growth

Global Biochips Anticipated Market to reach USD 25.84 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of personalized medicine and rapid technological advancements in the biochips market along with high market demand from proteomic and genomic applications is expected to drive market growth. 

Anticipated launch and commercialization of novel products for diagnosis and treatment including laboratory- and non-laboratory-based research are expected to further reinforce growth in demand. Improvements in accuracy, resolution, and preparation procedures for the technology coupled with reduction in costs of associated materials are expected to fuel growth over the forecast period. 

Ongoing developments related to further miniaturization of biochips are expected to enhance their applicability and additional usage for genetic sequencing methodologies, such as cancer genomics. Their usage is also expected to aid reduction in the cost of genome profiling, which is a factor likely to drive demand for the next step of genetic analysis, i.e., protein expression analysis. Consequently, a growth in the number of such protein profiling studies is expected to directly fuel demand for genomic and proteomic labelling techniques through to 2024. 

Access for full detail of Report and Complete TOC: http://www.grandviewresearch.com/industry-analysis/biochips-market

Further Key Findings From the Report Suggest:

• DNA chips form the largest revenue-generating segment of the biochip applications. Major contribution to this share comes from usage in cancer diagnostics/treatment and drug discovery applications. DNA chips accounted for around a third of the global market revenue in 2015. The other notable contributing segments to application of biochips include gene expression, single nucleotide polymorphism genotyping, genomic studies, and agricultural biotechnology.
• The market is expected to have a high potential for growth as the technology has numerous applications to aid the miniaturization of molecular biology and biochemical & chemical assays. Over time, such miniaturization is expected to benefit medical technologies in terms of cost and input requirements.
• DNA chips, lab-on-a-chip, protein chips, and tissue & cell arrays find a number of uses in pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic centers, and other end users like point-of-care settings, forensic labs, blood banks, etc.
• North America was the largest revenue-generating region and accounted for over 45%of total revenue in 2015. This can be attributed to by the presence of government initiatives for personalized patient care coupled with the availability of a very large installed base of genetic and proteomic profiling platforms across the U.S. High market usage of next-gen sequencing techniques for molecular diagnosis and treatment used with microfluidic techniques also add to the large share. Furthermore, cancer analysis projects in a number of academic and clinical research institutes are also responsible for the region’s large share.
• Some key players operating in this industry include Abbott Laboratories; PerkinElmer, Inc.; GE Healthcare; Illumina, Inc.; Thermo Fisher Scientific, Inc.; Merck Millipore; Agilent Technologies, Inc.; Sigma-Aldrich Corporation; Fluidigm Corporation; and Bio-Rad Laboratories, Inc. 

View all related Blogs from same Category: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Biochip market on the basis of type, end use, region:

Biochip Outlook, by Type (Revenue, USD Million, 2013 - 2024)
DNA chips, by application

• Cancer diagnosis and treatment
• Gene expression
• Single Nucleotide Polymorphisms Genotyping
• Genomics.
• Drug discovery
• Agricultural biotechnology
•  Others

Lab-on-a-chip, by application

• Genomics
• IVD & POC
• Proteomics
• Drug discovery
•  Others

Protein chips, by application

• Proteomics

• Expression Profiling
• Diagnostics
• HTS
• Drug Discovery
• Others

Tissue Arrays
Cell Arrays
Biochip Outlook, by End Use (Revenue, USD Million, 2013 - 2024)

• Biotechnology and Pharmaceutical Companies
• Hospitals and Diagnostics Centers
• Academic & Research Institutes
• Others

Biochip Regional Outlook (Revenue, USD Million, 2013 - 2024)
North America

• U.S.
• Canada

Europe

• Germany
•  UK

Asia Pacific

• China
• Japan

Latin America

•  Brazil

MEA

• South Africa

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us@ www.grandviewresearch.com

Middle East & Africa (MEA) Textile Market is expected to witness volume growth at a CAGR of 3.6% from a period of 2016 to 2025

Global Textile Market is expected to reach approximately USD 1,237.1 billion by 2025, according to a new report conducted by Grand View Research, Inc. Rising disposable income, urbanization and population growth in emerging economies including China, India and Mexico is expected to play an importance role in improving the lifestyle of consumers which is expected to drive the demand for textile products.

Product innovation is expected to have a positive impact on the industry; for instance, the Runway of Dreams brand launched by apparel manufacturer Tommy Hilfiger in February 2016. Furthermore, a growing number of fashion retail outlets and supermarkets in developing economies, including China and India, owing to government support to promote investments is expected to increase the textiles demand in the near future.

Access for full detail of Report and TOC: http://www.grandviewresearch.com/industry-analysis/textile-market

Further key findings from the report suggest:

• Transportation is anticipated to foresee revenue growth at a CAGR of 3.4% from 2016 to 2025. The enactment of numerous passenger safety regulations, including Euro VI petrol and diesel standard norms that regulate heavy-duty and light-duty vehicles, are expected to increase the usage of fabrics in automotive filters over the next nine years.
• The Middle East & Africa (MEA) is expected to witness volume growth at a CAGR of 3.6% from a period of 2016 to 2025. The rising expenditure by Islamic clothing manufacturers to incorporate new hijab styles in apparels is projected to increase the product usage over the next nine years.
• There is an increasing importance of EHS systems in the manufacturing sector, owing to stringent regulations aimed at worker safety and reporting incidents in offshore industries, including oil & gas, which is expected to increase the demand for personal protective equipment (PPE). The trend mentioned above is projected to play a vital role in increasing the market penetration of textiles in the form of technical fabrics in PPE over the forecast period.
• Polyester held a market volume share of 28.2% in 2015 and is expected to witness growth over the forecast period due to its superior properties including lightweight and excellent resistance to shrinking. Polyester is often used in combination with other fibers such as cotton as the blend offers properties superseding either of the materials.
• Cotton-based textile products’ demand was 93.6 million tons in 2015. Clothing manufacturers are expected to prefer cotton as their raw material on account of its unique features including resistance to hypoallergenic & dust mite, excellent durability, and environmentally friendly nature.
• Key industry participants include Shandong Jining, INVISTA, Honeywell International, and Asahi Kasei Fibers Corporation. The companies are expected to increase spending on the development of new products, including smart textiles and ballistic nylon, to gain a competitive edge over their competitors.

View all related reports from same Category: http://www.grandviewresearch.com/industry/specialty-glass-ceramic-and-fiber

Grand View Research has segmented the global textiles market on the basis of raw material, product, application, and region:

Raw Material Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2014 - 2025)

• Cotton
• Chemical
• Wool
• Silk
• Others

Product Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2014 - 2025)

• Natural-fibers
• Polyesters
• Nylon
• Others

Application Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2014 - 2025)

• Household
  • Bedding
  • Kitchen
  • Upholstery
  • Towel
  • Others
• Technical
• Construction
• Transportation
• Medical
• Protective
• Others
• Apparel
• Ties & Clothing Accessories
• Handbags
• Others
• Fashion & Clothing
• Others

Regional Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2014 - 2025)
North America

• U.S.
• Canada
• Mexico

Europe

• Russia
• UK
• Germany
• France
• Turkey
• Italy

Asia Pacific

• China
• India
• Japan
• Australia

Central & South America

• Brazil

MEA

• Saudi Arabia
• Iran

 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-textile-market
 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us@ www.grandviewresearch.com

Floating Solar Panels Market Variables, Trends and Scope 2014-2025

Global Floating Solar Panels Market is expected to reach USD 2.70 billion by 2025, according to a new report by Grand View Research, Inc. The technology is expected to witness significant growth over the forecast period owing to rising demand for reliable renewable power generation. Furthermore, the ability to mitigate land cost is expected to favour demand over the projected period.
The growing focus of various governments towards the use of renewable energy for power generation coupled as well as lower environmental pollution by reducing the dependence on fossil fuels is expected to have a positive impact over the projected period.

Declining panel cost leading to lower per unit cost of generation is a key factor promoting the use of solar technology for power generation. Furthermore, lack of availability of suitable land for installation coupled with its ability to lower the impact of evaporation is a key factor driving the market over the forecast period.

Access for full Detail of Report and TOC: http://www.grandviewresearch.com/industry-analysis/floating-solar-panels-market

Further key findings from the report suggest:

• The penetration of stationary floating solar technology is expected to grow, particularly in developing and emerging economies owing to the low cost of installation as compared to its counterpart.
• Tracking floating solar panels are expected to grow over the next nine years owing to the increased efficiency of the panels with tracking technology. The growing R&D investments by the installers and panel manufacturers to reduce the cost of this particular technology are likely to bolster market growth.
• Japan accounted for over 75% of the overall revenue share in 2015 owing to the low availability of land and favourable initiatives taken by the government to promote the use of renewable sources of energy. In addition, the industry is expected to grow substantially on account of the numerous plans sanctioned by the Japanese government.
• Europe is one of the leading installers of the technology owing to the rising market penetration in the UK with around six plants and an installed capacity of over 10,000 kW of the overall installations in Europe.
• Key players in the industry include Kyocera Corporation, Trina Solar, Sharp Corporation and Yingli Solar. Ciel & Terre is expected to be the largest installer of floating panels across the globe. The company accounts for over 50% of the overall floating panels installations.

View all related reports from same category: http://www.grandviewresearch.com/industry/renewable-energy

Grand View Research has segmented the floating solar panels market on the basis of product and region:

Product Outlook (Installed Capacity, Kilowatt; Revenue, USD Million, 2014 - 2025)

• Tracking Solar Floating Panels
• Stationery Solar Floating Panels

Regional Outlook (Installed Capacity, Kilowatt; Revenue, USD Million, 2014 - 2025)

• U.S.
• Europe
• Asia Pacific
• Japan
• Central & South America
• Rest of the World

 
Read Blog on Floating Solar Panels Market by Grand View Research: http://www.grandviewresearch.com/blog/floating-solar-panels-market-size-trends   

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us@ www.grandviewresearch.com

Bioactive Ingredient Market Quantitative Analysis by Market size, estimates, and forecast from 2014 to 2024

Global Bioactive Ingredient Market is expected to reach USD 51.71 billion by 2024, according to a new report by Grand View Research, Inc. Increasing disposable income coupled with growing health awareness among consumers is expected to aid the market growth. Their functional properties are capable of acting on the human metabolism physiology by providing potential health benefits.

The extraction of these bioactive compounds from original sources provides ample opportunities for adding value to food products and also improves the dietary patterns of the changed consumer’s lifestyle. They also help in preventing diseases related to heart, cancer, degenerative forms and Alzheimer’s.

Marine environment is a significant source for yielding bioactive components. Consumption of long-chain fatty acids by some fish species is strongly associated with protection from coronary heart diseases (CHD). Fish Origin Omega 3 PUFA oil are claimed to have a lot of health benefits related to a person’s diet.

Recently, it has been reported that there is an increasing demand for fish oils and fish oil fortified products across various regions. Marine organisms are potentially identified for calcium, antioxidants, anti-hypertensive proteins, selenium, and chitin. Their usage in functional food segment is regarded as the most important part and is expected to affect the overall market over the next eight years.
However, extraction of medicines derived from plants is affecting the environment by causing deforestation and is expected to affect the industry critically over the forecast period. Also, to meet the rising consumer's interest for these products, manufacturers is putting a lot of pressure on the marine organisms.

Recent technological advances such as microencapsulation are adopted for protecting bioactive ingredients from unwanted reactions and oxidation. There is a rising demand among manufacturers to find suitable solutions that provide higher productivity and adequate quality of the final products.

Access for full detail of report and TOC: http://www.grandviewresearch.com/industry-analysis/bioactive-ingredients-market

Further key findings from the report suggest:

• Fibers were the leading product segment and accounted for over 25% of global revenue in 2015. The effectiveness of fibers and rising awareness regarding its benefits are the primarily attributed reasons for this scenario.
• Functional food & beverage product segment is expected to witness the highest CAGR of 7.4% over the forecast period. The consumers owing to its potential health benefits prefer this segment.
• Asia Pacific was the leading consumer and accounted for over 35% of total revenue in 2015. The region is also expected to witness the highest growth of 7.5% over the next eight years. Changing lifestyle coupled with rising health consciousness among people particularly in China and India is drive the regional growth.
• Key industry participants include Mazza Innovation Ltd., Sabinsa Corporation, Ingredion Incorporated, BASF, Cargill Inc, Ajinomoto Co. Inc, Archer Daniel Midland Company and DuPont.

View for all related reports from same Category: http://www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements 

Grand View Research has segmented the bioactive ingredient market on the basis of product, application and region:

Global Bioactive Ingredients Product Outlook (Revenue, USD Billion, 2014 - 2024)

• Fiber
• Vitamins
• Omega 3 PUFA
• Plant extracts
• Minerals
• Carotenoids & antioxidants
• Probiotics
• Other types

Global Bioactive Ingredients Application Outlook (Revenue, USD Billion, 2014 - 2024)

• Functional food & beverages
• Dietary supplements
• Clinical Nutrition
• Personal care
• Other products

Global Bioactive Ingredients Regional Outlook (Revenue, USD Billion, 2014- 2024)
North America

• U.S.

Europe

• Germany
• UK
• France

Asia Pacific

• China
• India

Central & South America
Middle East & Africa
 
Browse Research Insight by Grand View Research: http://www.grandviewresearch.com/research-insights/bioactive-ingredients-products-market-insights 

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us@ www.grandviewresearch.com

Breathable Film Market demand is expected to grow at a CAGR of 5.6% from 2016 to 2024

Global Breathable Film Market is expected to reach USD 22.83 billion by 2024 according to a new report by Grand View Research, Inc. The growing demand for breathable films in the packaging, healthcare, hygiene, and apparel industry is anticipated to drive market demand over the coming years. 

The breathable film market is strongly influenced by new product developments and expansions into emerging markets. The increasing use of breathable films in hygiene and building & construction market is anticipated to boost the market growth in Asia Pacific. Stringent regulations concerning use of protective apparel in the healthcare and industrial sector are expected to augment future market growth. 

Rising demand for waterproof garments in sports apparels is projected to propel the demand for breathable films over the forecast period. Increasing investments in the healthcare sector is expected to drive the demand for masks, gloves, drapes, sheets, and other disposable garments over the coming years.

Access for full detail of report: http://www.grandviewresearch.com/industry-analysis/breathable-film-market

Further key findings from the report suggest:

• The global breathable film market demand was 5.48 million tons in 2015 and is expected to reach 8.92 million tons by 2024, growing at a CAGR of 5.6% from 2016 to 2024
• Polyester dominated the breathable film market in 2015 accounting for around 33% of the global market demand in the raw material segment. It is also expected to witness the highest growth of 6.0% over the forecast period.
• Non-porous films were the leading product segment and accounted for over 70% of global demand in 2015. Increasing penetration for healthcare and food packaging application is expected to drive this segment over the forecast period.
• The packaging segment occupied the largest share in 2015, on account of growing demand for breathable films in the convenience food, confectionery & bakery products, meat, and processed food market.
• Asia Pacific is anticipated to witness a significant growth over the forecast period on account of the growing building & construction and manufacturing sector
• The increasing demand for protective apparel in the medical and industrial sector of North America and Europe is anticipated to boost future market growth in this region.
• Major companies identified in the market include Argotec LLC., Arkema, Clopay Plastics, Fatra, a.s., Kimberley-Clark, and Nitto Denko Corporation among others. 

Borrows Related report from same Category: http://www.grandviewresearch.com/industry/specialty-and-fine-chemicals 

Grand View Research has segmented the breathable film market on the basis of raw material, product, application, and region:

Global Breathable Films Raw Material Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)

• Polyester
• Polyethylene
• Polypropylene
• Others

Global Breathable Films Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)

• Microporous
• Microvoid
• Non-porous

Global Breathable Films Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)

• Hygiene
• Healthcare
• Building & Construction
• Industrial Protective Apparels
• Packaging
• Sports Apparels
• Others

Global Breathable Films Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)
North America

• U.S.

Europe

• Germany
• UK
• France

Asia Pacific

• China
• India
• Japan
• Malaysia
• Indonesia
• Thailand

Central & South America

• Brazil

Middle East & Africa

• Saudi Arabia

 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-breathable-film-market 
 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com

Breast Imaging Market Quantitative Analysis by Market Size, Estimates, and Forecast from 2013 to 2024

Global Breast Imaging Market is expected to reach USD 7.3 billion by 2024, according to a new report by Grand View Research, Inc. The increasing incidences of breast cancer coupled with the continual product improvements being launched and the numerous R&D innovation initiatives being undertaken in the field of cancer are expected to collectively boost the growth of the market over the forecast period.

In 2012, the WHO estimated that around 53.0% of the global women population (1.8 billion women) is anticipated to suffer from breast cancer over their lifespan. This alarmingly rising rate is expected to be the preliminary driver for this market over the forecast period.

The rising base of the geriatric population is another high impact rendering driver of the breast imaging market. A study by the NCBI (National Center for Biotechnology Information) stated that the incidence of breast cancer is higher in patients above the age group of 45.

Increasing expenditure on R&D coupled with government funding are the other vital factors expected to trigger market growth over the forecast period. In 2013, the National Institute of Health, in the U.S. provided a grant amounting to USD 5.6 billion to conduct research on breast cancer. Digital mammography is one of the technologies gaining popularity as compared to other technologies, which is expected to positively reinforce this market’s growth.

However, the high cost of the existing imaging systems coupled with the stringent regulatory policies governing the approval of new products and marketing are predicted to slowdown growth.

Access for full detail of the Report: http://www.grandviewresearch.com/industry-analysis/breast-imaging-equipment-market

Further key findings from the study suggest:

• The 3D tomo synthesis segment is identified as the fastest growing segment. This technology offers enhanced efficiency and higher diagnostic accuracy in comparison to other available technologies, which is expected to aid market growth.
• North America is likely to dominate throughout the forecast period with a revenue share of over 30.0% by 2024.Government initiatives including the precision medicine initiative, started by President Obama in 2015, promotes the development of personalized medicine, which is anticipated to foster market growth.
• Asia Pacific is anticipated to grow at the fastest rate of12.0% over the forecast period. The Increasing number of investments in the healthcare sector coupled with the rising awareness of breast cancer and other associated conditions is anticipated to propel the market growth in this region.
• Some major players of the market are Siemens Healthcare, GE Healthcare, Dilon Technologies, Inc., Hologic, Inc., Gamma Medica, Inc., Fujifilm Holdings Corporation, SonoCine, Inc., Philips Healthcare, Toshiba Corporation, and Aurora Imaging Technology, Inc.
• In order to gain a competitive advantage in the market, the key industry players are adhering to mergers, acquisitions and collaborative agreements. For instance, in January 2016, Gamma Medica, Inc. entered into a contract with Alpha Imaging Technology Corp. for the commercialization of its new product, Luma GEM.

Borrows all related Reports from same Category: http://www.grandviewresearch.com/industry/medical-imaging  

Grand View Research has segmented Breast Imaging market on the basis of technology and region.

Global Breast Imaging Market Technology Outlook (Revenue, USD Million, 2013 – 2024)

• Ionizing technology
  • Full-Field Digital Mammography
  • Analog Mammography
  • Positron Emission Mammography
  • Electrical Impedance Tomography
  • Cone Beam Computed Tomography
  • Positron Emission Tomography & Computed Tomography
  • 3D Breast Tomosynthesis
• Molecular breast imaging/breast-specific gamma imaging (MBI/BSGI)
• Non-ionizing technology
• Breast MRI
• Breast Thermography
• Breast Ultrasound
• Optical Imaging
• Automated Whole-Breast Ultrasound

Breast Imaging Market Regional Outlook (Revenue, USD Million, 2013 – 2024)
North America

• U.S.
• Canada

Europe

• UK
• Germany

Asia Pacific

• Japan
• China

Latin America

• Brazil
• Argentina

MEA

• South Africa
• Saudi Arabia

 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-breast-imaging-equipment  
 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com

Blood Screening Market Variables, Trends and Scope 2013-2024

Global Blood Screening Market is expected to reach a value of USD 3.9 billion by 2024, based on a new report by Grand View Research, Inc. The growth of the market is attributed to the increasing screening of donor and continuous technological advancements by the market players. Demand for blood screening tests are increasing continuously due to increasing donation, rising awareness about transfusion-transmitted diseases, and technological developments in the industry.

Thorough screening is necessary for all donated blood to ensure that recipients receive the safest products. As of 2015, such testing consists of screening for red cell antibodies, and the infectious diseases agents: HIV-1, HIV-2, hepatitis virus, West Nile Virus (WNV), Human T-Lymphotropic Virus (HTLV) T. Cruzi, and T. pallidum (syphilis). Result of all these assays must be negative for blood donation.

Technological developments in the market increase the sensitivity and efficiency of the tests. For instance, in 2016, the U.S. FDA approved the Procleix Zika virus assay from Hologic, Inc. and Grifols to screen donated blood. Furthermore, the U.S. FDA approved next-generation sequencing (NGS) technology in 2013. The technology is cheaper and faster than previous DNA analysis methods.

Access for full detail of the Report: http://www.grandviewresearch.com/industry-analysis/blood-screening-market

Further Key Findings from the Study Suggest:

• Nucleic acid amplification test or nucleic acid test (NAT) is expected to be the fastest growing segment during the forecast period. It comprises transcription mediated amplification (TMA) tests and polymerase chain reaction. Increasing demand of NAT over ELISA test due to high sensitivity and specificity for viral nucleic acid is contributing to the fastest growth during the forecast period.
• In 2015, reagent dominated the product segment. Introduction of new assays for the detection of various diseases is expected to enable the segment to gain the maximum share of market in the coming years. For instance, in January 2015 the FDA approved Roche’s blood screening assay COBAS TaqScreen MPX Test for the detection and identification of HCV, HIV, and HBV. 
• In 2015, regionally North America dominated with a revenue share of more than 40%. Government initiatives, presence of major players, and more patient affordability are the major factors that contributed toward its dominance.
• In August 2016, the FDA recommended the testing of all the donated blood in the U.S. and its territories for Zika virus in order to prevent transmission of this virus through the blood supply.
• Asia Pacific is expected to be the fastest growing region due to increasing investment of industry players, government initiatives, and rising awareness about transmission of diseases during its transfusion.
• The Red Cross in Japan entered into a contract with Grifols for nucleic acid testing (NAT) for a blood donation camp in Japan in 2014. This agreement is anticipated to propel the NAT market during the forecast period. However, low donation as compared to requirement and high cost of kits and instruments are likely to restrain the growth in low-income countries during the forecast period.

Borrows all related reports from same Category: http://www.grandviewresearch.com/industry/clinical-diagnostics 

Grand View Research has segmented the blood screening market by technology, product and region:

Blood Screening Market Technology Outlook (Market Revenue in USD Million, 2013 - 2024)

• Nucleic Acid Amplification Test (NAT)
• ELISA
• Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
• Next-Generation Sequencing (NGS)
• Western Blotting

Blood Screening Market Product Outlook (Market Revenue in USD Million, 2013 - 2024) 

• Reagent
• Instrument

Blood Screening Market Regional Outlook (Market Revenue in USD Million, 2013 - 2024)
North America

• U.S.
• Canada

Europe

• UK
• Germany

Asia Pacific

• Japan
• China

Latin America

• Brazil

Middle East and Africa

• South Africa

 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-blood-screening-market   
 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com